🔎 Trials Near Me

Home › Interstitial Lung Diseases › South Carolina › Charleston

Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Charleston, SC

Isang pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Charleston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Nagre-recruitPhase 3
  • Lowcountry Lung and Critical Care, Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Nagre-recruitPhase 3
  • Medical University of South Carolina, Charleston
Edad 40 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Nagre-recruitPhase 2
  • MUSC, Charleston
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05798923

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Nagre-recruit
  • Medical University of South Carolina, Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07269262

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Nagre-recruitPhase 2
  • Medical University of South Carolina, Charleston
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Nagre-recruitPhase 2
  • Clinical Research Site, Charleston
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Nagre-recruit
  • Medical University of South Carolina, Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Nagre-recruitObservasyonal na pag-aaral
  • Medical University of South Carolina, Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Nagre-recruitPhase 2
  • Medical University of South Carolina (MUSC), Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Nagre-recruitObservasyonal na pag-aaral
  • Medical University of South Carolina, Charleston
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Nagre-recruitPhase 3
  • Medical University of South Carolina-Nexus, Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Nagre-recruitObservasyonal na pag-aaral
  • Medical University of South Carolina, Charleston
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06129240

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Nagre-recruitPhase 2
  • aTyr Investigative Site, Charleston
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2025 · NCT05892614

Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod

Iba pang pag-aaral sa Charleston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.